
Genetron Holdings Limited GTH
Annual report 2022
added 12-21-2024
Genetron Holdings Limited ROA Ratio 2011-2025 | GTH
Annual ROA Ratio Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -33.12 | -155.8 | -117.88 | -143.32 | -95.28 | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -33.12 | -155.8 | -109.08 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
-8.53 | $ 16.82 | -0.18 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 16.38 | 3.97 % | $ 170 M | ||
|
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-146.1 | $ 1.6 | -1.23 % | $ 2.03 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
3.43 | $ 39.39 | 1.97 % | $ 1.09 B | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
5.03 | $ 228.73 | 0.98 % | $ 167 B | ||
|
DarioHealth Corp.
DRIO
|
-61.65 | $ 11.97 | 0.67 % | $ 340 M | ||
|
DexCom
DXCM
|
8.64 | $ 67.19 | 0.34 % | $ 25.9 B | ||
|
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.46 | -0.04 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
-3.5 | $ 27.23 | 0.31 % | $ 823 M | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-40.76 | $ 20.72 | 0.78 % | $ 1.11 B | ||
|
Celcuity
CELC
|
-45.6 | $ 105.02 | -0.22 % | $ 4.14 B | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
-58.14 | $ 3.41 | -4.75 % | $ 109 K | ||
|
Co-Diagnostics
CODX
|
-37.07 | $ 0.33 | -3.34 % | $ 9.68 M | ||
|
Quidel Corporation
QDEL
|
43.3 | $ 28.72 | -0.28 % | $ 1.21 B | ||
|
Guardant Health
GH
|
-29.37 | $ 103.82 | 1.72 % | $ 12.7 B | ||
|
IQVIA Holdings
IQV
|
5.1 | $ 223.38 | 0.52 % | $ 40.5 B | ||
|
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-19.4 | $ 135.16 | 0.22 % | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
0.29 | $ 197.73 | 2.46 % | $ 10.2 B | ||
|
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 184.0 | 0.82 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
-44.15 | $ 7.85 | - | $ 1.02 B | ||
|
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 264.75 | 0.22 % | $ 22.2 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 187.27 | 0.37 % | $ 15.4 B | ||
|
IDEXX Laboratories
IDXX
|
26.96 | $ 707.12 | 0.41 % | $ 58.3 B | ||
|
Lantheus Holdings
LNTH
|
15.78 | $ 66.85 | 0.35 % | $ 4.63 B | ||
|
Agilent Technologies
A
|
11.3 | $ 140.96 | 0.93 % | $ 42.9 B | ||
|
Mettler-Toledo International
MTD
|
26.64 | $ 1 405.6 | 0.84 % | $ 29.8 B | ||
|
Myriad Genetics
MYGN
|
-12.39 | $ 7.22 | 0.14 % | $ 654 M | ||
|
Biomerica
BMRA
|
-83.65 | $ 2.53 | -1.94 % | $ 5.81 M | ||
|
Bioventus
BVS
|
-19.27 | $ 7.64 | 1.13 % | $ 479 M | ||
|
NeoGenomics
NEO
|
-4.81 | $ 11.87 | 0.16 % | $ 1.5 B | ||
|
Neogen Corporation
NEOG
|
-31.71 | $ 6.82 | -0.66 % | $ 1.48 B | ||
|
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K |